*Correspondence: Tina Vilsbll [email protected] This article was submitted to Cellular Endocrinology, a section of the journal Frontiers in Endocrinology Disclaimer All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers
For patients transitioning from semaglutide to tirzepatide , the BMI documentation is especially important because the patient weight may have already decreased from their initial obesity diagnosis
Changing the dose without supervision may increase the risk of side effects, poor response, hormone-related concerns, or unsafe stacking with other products
If you experience these symptoms, consult your doctor to determine the underlying cause and explore potential treatment options
Unlike earlier growth hormone releasing peptides, ipamorelin is highly selective and does not significantly stimulate ACTH, cortisol, or prolactin release at effective doses [1] [3]
Notation of interest: Methylcobalamin B12, is often considered beneficial for individuals with Methylenetetrahydrofolate reductase (MTHFR) gene mutation